Ikofficial Ikofficial
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Forums
  • Yazı
  • Blogs
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • Ruchika Thakur bir ses eklendi Other
    2026-06-30 05:49:41 -
    Global Monoclonal Antibody Market Size, Trends, Opportunities & Forecast 2035
    Monoclonal Antibody Market Overview According to MarketGenics, the global Monoclonal Antibody Market is witnessing remarkable growth, driven by increasing demand for targeted therapies, rising prevalence of chronic diseases, and rapid advancements in biotechnology. The market is expected to expand significantly throughout the forecast period as pharmaceutical companies continue investing in...
    0 Yorumlar 0 hisse senetleri 35 Views 0 önizleme
    Please log in to like, share and comment!
  • Subhayan Mayra bir ses eklendi Other
    2026-06-24 13:17:02 -
    Global Pembrolizumab Market Growing at 7.3% CAGR Through 2034
    According to a new report from Intel Market Research, the global Pembrolizumab market was valued at USD 21.8 billion in 2025 and is projected to grow from USD 24.3 billion in 2026 to USD 42.7 billion by 2034, exhibiting a robust CAGR of 7.3% during the forecast period. This growth is driven by increasing cancer prevalence, rising immunotherapy adoption, expanding regulatory approvals for new...
    0 Yorumlar 0 hisse senetleri 217 Views 0 önizleme
    Please log in to like, share and comment!
  • Subhayan Mayra bir ses eklendi Other
    2026-06-12 10:21:20 -
    United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
    The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...
    0 Yorumlar 0 hisse senetleri 568 Views 0 önizleme
    Please log in to like, share and comment!
© 2026 Ikofficial Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Contact Us Rehber